GILD News Alert Gilead Sciences (GILD) 107.34 09/25/2014 21:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gilead Sciences (GILD) 107.34 $GILD

Seattle Genetics' Adcetris Positive in Durability Analysis - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 25, 5:27PM CDT
Seattle Genetics, Inc. (SGEN) announced data from a two-year durability analysis of a phase I study on Adcetris for newly diagnosed mature T-cell lymphoma (MTCL).

Final Glance: Biotechnology companies
AP - Thu Sep 25, 5:02PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were down at the close of trading:

Acorda Skyrockets on $525M Civitas Therapeutics Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 25, 4:47PM CDT
Acorda is set to acquire privately-held biopharmaceutical company, Civitas Therapeutics.

Gilead Scores with TAF-based HIV Regimen, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 25, 4:20PM CDT
Gilead's (GILD) TAF- based STR performed well in two late-stage studies.

Genomic Health Upbeat on Strong International Performance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 25, 2:00PM CDT
Genomic Health (GHDX) is focused on delivering revenue growth through constant investment for higher adoption of its tests across three major cancers

Midday Glance: Biotechnology companies
AP - Thu Sep 25, 12:24PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 1 p.m.:

This Switch Could Make Gilead Sciences, Inc. Stock Billions
Brian Orelli, The Motley Fool - Motley Fool - Thu Sep 25, 11:01AM CDT
What's in a name? For Gilead Sciences , a few billion dollars. Tenofovir alafenamide and tenofovir disoproxil fumarate may sound similar enough (and also a mouthful), but tenofovir alafenamide, commonly referred to as TAF, is worth a heck of a...

Early Glance: Biotechnology companies
AP - Thu Sep 25, 10:40AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:

Stock Market News for September 25, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Thu Sep 25, 9:10AM CDT
Markets rebounded on Wednesday after taking losses in three straight sessions

Immunomedics Inc. (IMMU) Jumps: Stock Up 6.6% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Sep 25, 8:39AM CDT
Immunomedics Inc. (IMMU) was a big mover last session, as the company saw its shares rise almost 7% on the day.

The Best Biotech Stock for Your Growth Portfolio
Motley Fool Staff - Motley Fool - Thu Sep 25, 7:45AM CDT
For those willing to endure the inevitable price roller coaster, there's tremendous opportunity in hyper-growth biotech stocks. But you have to pick the best stocks if you're going to generate market-beating returns. So we asked each of our analysts...

The Medicines Patent Pool Adds New Sub-Licensing Agreements to Improve Access to Novel ARVs in Developing Countries
PR Newswire - Thu Sep 25, 6:59AM CDT
MPP signs sub-licences with six generic manufacturers for the development of Phase III drug Tenofovir Alafenamide

'Fast Money' Recap: What Market? The Focus Remains on Apple
at The Street - Thu Sep 25, 4:00AM CDT
The trading panel discussed how low the market can go and whether biotech stocks can continue to move higher.

Jim Cramer's 'Mad Money' Recap: Why You Can't Get Too Negative in This Market
at The Street - Wed Sep 24, 7:24PM CDT
Investors always need to be prepared for when common sense returns to the market, Cramer says.

Gilead reports good HIV trial
at Investor's Business Daily - Wed Sep 24, 5:30PM CDT
The biotech reported good late-stage trial data for its new HIV drug. The trial compared a standard combination of drugs in Gilead's (GILD) Stribild to a trial in which 1 of the components, sold individually as Viread, was replaced with tenofovir...

Novavax's Influenza Vaccine Study Shows Adjuvant Efficiency - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 5:10PM CDT
Novavax, Inc. (NVAX) announced positive top-line data from a phase I/II study on influenza vaccine candidate, H7N9 VLP.

Gilead (GILD) Seeks Japanese Approval for HCV Combo Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 5:00PM CDT
Gilead (GILD) is seeking Japanese approval for the combination of Sovaldi and ledipasvir .

Celgene's Otezla Label Expanded to Include Plaque Psoriasis - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 4:30PM CDT
Celgene's (CELG) Otezla gained FDA approval for plaque psoriasis.

Emergent BioSolutions Initiates Pivotal Study on BioThrax - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 4:20PM CDT
Emergent BioSolutions (EBS) initiated a pivotal non-clinical study on BioThrax to support the licensure of the company's new modern facility, Building 55.

Watch for Gilead Sciences to Potentially Pullback After Gaining 3.10% Yesterday
Comtex SmarTrend(R) - Wed Sep 24, 3:37PM CDT
Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $106.02 to a high of $108.81. Yesterday, the shares gained 3.1%, which took the trading range above the 3-day high of $107.89 on volume of 14.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Racura's AML Trial Clears Its First Crucial Hurdle

Updated Category News Views 95

One signature from Sheba does not cure leukemia, but it does move Racura Oncology from talking about EMILI to doing the hard, expensive work of enrolling patients. For a company at this stage, that distinction matters. Ethics approval for the seamless Phase 2b/3 RC220 study in relapsed or refractory acute myeloid leukemia is a real operational milestone, not the sort of...

Continue Reading
Barcelona Housing Summit Puts Affordability on the Map

Updated Category News Views 86

A packed Barcelona hall cannot magically unjam a housing market, but it can force the grown-ups in the room to stare at the mess. Housing World Summit, known as HOWS Barcelona, closed its first edition with 1,530 attendees and a broad cast: city officials, governments, developers, investors, third-sector groups and academics. That mix matters because affordable housing is...

Continue Reading
Panama City Beach Rentals: Rules Before the Ocean View

Updated Category News Views 102

A postcard-perfect balcony can hide a remarkably expensive rulebook. That is the unglamorous message in Angie Outlaw’s discussion of vacation-property buying in Panama City Beach: the view may sell the unit, but zoning, association documents, insurance and lender terms determine whether the purchase behaves anything like the income-producing asset a buyer pictured. I...

Continue Reading
Innoviz's 1-for-20 Split Is a Listing Lifeline Test

Updated Category News Views 93

A twenty-share pile of INVZ is about to become one share, and nobody should confuse that paperwork with a turnaround. Innoviz plans to enact a 1-for-20 reverse split at 11:59 p.m. Eastern on Friday, December 4, with split-adjusted trading expected when Nasdaq opens on December 7. This is a blunt instrument aimed at one immediate problem: getting the quoted share price...

Continue Reading
AWK Adds Fayette Water System With $9M Upgrade Plan

Updated Category News Views 121

Small water systems do not usually collapse in one dramatic heap; they get worn down by scattered pipes, compliance demands, thin staffing and bills nobody wants to raise. That is the backdrop for Pennsylvania American Water’s completed $32.8 million purchase of the Indian Creek Valley Water Authority system. For American Water shareholders, this is the familiar...

Continue Reading
RazorMetrics' Fast 500 Run Merits a Harder Investor Look

Updated Category News Views 75

A 4,488% growth figure can make even a seasoned skeptic sit upright. RazorMetrics landed at No. 20 on Deloitte's 2026 Technology Fast 500 after ranking No. 12 in 2025, and it again took the top Texas slot. That is serious momentum for an Austin company working on one of healthcare's most stubborn expenses: prescription drugs. Still, this is healthcare cost containment,...

Continue Reading
Scenthound’s Franchise Award Spotlights a Real Test

Updated Category News Views 111

A clean dog may not sound like a growth story, yet Scenthound has turned that neglected chore into a surprisingly serious franchise proposition. The company has won the International Franchise Association’s Emerging Franchisor Award after building its dog-hygiene concept from a 2015 founding into a network with more than 180 open locations. That is a respectable piece...

Continue Reading
Rare Stellar Merger Validates RIT Theory in Nature

Updated Category News Views 72

One star swallowed another’s orbit, and astronomy finally caught the evidence. That is the plain-English punch of the observation called AT 2025abao in the Andromeda Galaxy, and it is a meaningful one for Jason Nordhaus and his colleagues at Rochester Institute of Technology. On Nov. 18, research published in Nature validated a scenario Nordhaus’s team had predicted...

Continue Reading
Nightguards and TMJ Appliances Require Different Calls

Updated Category News Views 139

Two clear plastic devices can invite a costly wrong turn. Dr. Terrance O’Keefe’s explanation, published Nov. 18, 2026, draws a line that patients too often blur: a nightguard protects teeth from grinding, while a TMJ appliance is meant to address joint and muscle strain tied to temporomandibular disorders. They may look alike sitting in a case. Their jobs are not...

Continue Reading
Cytonics Refines CYT-108 Trial Plan With Decade OA Data

Updated Category News Views 119

A Better Map Is Not a Working Drug Knee osteoarthritis has chewed up plenty of promising development plans because the disease moves at an aggravatingly uneven crawl. Cytonics has done something sensible before pushing deeper into CYT-108: it went back to long-term untreated patient data and asked which knees actually deteriorate fast enough for a trial to detect...

Continue Reading

Top 5 Most Recently Viewed Articles

Ollie's Bargain Outlet Raises Over $1.3 Million for Charity

Updated Category News Views 216

Ollie's Bargain Outlet Makes a Difference this Holiday Season Ollie's Bargain Outlet recently announced an impressive fundraising effort, raising over $1.3 million for the Marine Toys for Tots Program. This initiative highlights the company's commitment to giving back to the community during the holiday season. From early November to early December, participating Ollie's...

Continue Reading
Navigating the Integer Holdings Corporation Class Action Concerns

Updated Category News Views 147

Your Rights as an Investor in Integer Holdings Corporation If you've invested in Integer Holdings Corporation (NYSE: ITGR), you might be feeling concerned about recent developments. The company, known for its role in cardiac rhythm management and cardiovascular product manufacturing, is currently under scrutiny due to allegations that it misled investors regarding the...

Continue Reading
Indochino Welcomes Sean Wrenn as New Vice President of Retail

Updated Category News Views 163

Indochino Welcomes Sean Wrenn as New Vice President of Retail INDOCHINO, the leader in made to measure apparel, has appointed Sean Wrenn as the new Vice President of Retail Sales and Operations. With over two decades of retail experience, Sean is set to enhance the company’s operations and customer engagement. Sean Wrenn's Background and Expertise Sean Wrenn joins...

Continue Reading
Innovative Partnership Enhances Efficiency in Dairy Processing

Updated Category News Views 200

Collaboration to Boost Dairy Processing Efficiency In an exciting development within the dairy processing sector, CADDi, a renowned provider of digital solutions for manufacturers, has teamed up with Dairy Conveyor Corporation (DCC Automation). This collaboration marks a significant step towards optimizing supply chains and fostering better communication across DCC's...

Continue Reading
Celebrating Food and Beverage Excellence in the Middle East

Updated Category News Views 171

Celebrating Excellence in Food and Beverage The Middle East Food & Beverage Excellence Awards is an annual event that brings together the best in the industry, turning the spotlight on the remarkable achievements of food and beverage professionals. Last night, at the stunning JW Marriott Marina, industry leaders in the Middle East gathered for an unforgettable evening...

Continue Reading